Skip to main content

Pediatric Cancer in the Head and Neck

  • Chapter
  • First Online:
Pediatric Malignancies: Pathology and Imaging

Abstract

Malignant tumors that predominantly occur in the head and neck region in children and adolescents may be grouped according to their primary anatomic locations such as nasal cavities and sinuses, oral cavity and salivary gland, ear region, and thyroid gland. Aside from sarcomas, the most common cancers in nasal cavities and sinuses in pediatric population include nasopharyngeal carcinoma and esthesioneuroblastoma. Non-sarcoma childhood malignancies in oral cavity and salivary gland include mucoepidermoid carcinoma, sialoblastoma, and HPV-related carcinoma. Pediatric ear tumors include paraganglioma and rhabdomyosarcoma, the latter being also common in other head and neck locations such as nasal cavity. Pediatric thyroid cancers include papillary and follicular carcinomas, and medullary thyroid carcinoma. NUT midline carcinoma is a newly described aggressive tumor, the majority arising in midline structures of head and neck or thorax. Melanotic neuroectodermal tumor of infancy is a unique tumor that primarily occurs in the mandible or maxilla. This chapter also briefly discusses lymphomas and sarcomas that may affect head and neck region, but the pathological features of these tumors are similar to the same types of tumors occurring in other anatomic locations outside head and neck region. Therefore readers are referred to other chapters in this book for details.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Zhou J, Michaud DS, Langevin SM, McClean MD, Eliot M, Kelsey KT. Smokeless tobacco and risk of head and neck cancer: evidence from a case-control study in New England. Int J Cancer. 2013;132(8):1911–7. Epub 2012/09/19. doi: 10.1002/ijc.27839, PubMed PMID: 22987222; PubMed Central PMCID: PMC3552089.

    PubMed Central  CAS  PubMed  Google Scholar 

  2. Hashibe M, Hunt J, Wei M, Buys S, Gren L, Lee YC. Tobacco, alcohol, body mass index, physical activity, and the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian (PLCO) cohort. Head Neck. 2012. Epub 2012/06/20. doi: 10.1002/hed.23052. PubMed PMID: 22711227.

    Google Scholar 

  3. Dufour X, Beby-Defaux A, Agius G, Lacau St Guily J. HPV and head and neck cancer. Eur Ann Otorhinolaryngol Head Neck Dis. 2012;129(1):26–31. Epub 2011/09/29. doi: 10.1016/j.anorl.2011.05.004, PubMed PMID: 21944953.

    CAS  PubMed  Google Scholar 

  4. Robson CD. Imaging of head and neck neoplasms in children. Pediatr Radiol. 2010;40(4):499–509. doi: 10.1007/s00247-009-1526-9, PubMed PMID: 20225112.

    PubMed  Google Scholar 

  5. Engleson J, Soller M, Panagopoulos I, Dahlen A, Dictor M, Jerkeman M. Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy. BMC Cancer. 2006;6:69.

    PubMed Central  PubMed  Google Scholar 

  6. Galioto S, Di Petrillo A, Pastori M, Arecchi A. Metastatic esthesioneuroblastoma secreting adrenocorticotropic hormone in pediatric patients. J Craniofac Surg. 2011;22(5):1924–9.

    PubMed  Google Scholar 

  7. Jadvar H, Connolly LP, Fahey FH, Shulkin BL. PET and PET/CT in pediatric oncology. Semin Nucl Med. 2007;37(5):316–31. doi: 10.1053/j.semnuclmed.2007.04.001, PubMed PMID: 17707239.

    PubMed  Google Scholar 

  8. Barnes L, Eveson JW, Reichart P, et al., editors. World Health Organization classification of tumors: pathology and genetics of head and neck tumors. Lyon: IARC Press; 2005.

    Google Scholar 

  9. Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2006;15(10):1765–77.

    CAS  PubMed  Google Scholar 

  10. Ablashi DV, Levine PH, Prasad U, Pearson GR. Fourth international symposium on nasopharyngeal carcinoma application of field and laboratory studies to the control of NPC. Cancer Res. 1983;43(5):2375–8.

    CAS  PubMed  Google Scholar 

  11. Shanmugaratnam K. Nasopharyngeal carcinoma: epidemiology, histopathology and aetiology. Ann Acad Med. 1980;9(3):289–95.

    CAS  Google Scholar 

  12. Nam JM, McLaughlin JK, Blot WJ. Cigarette smoking, alcohol, and nasopharyngeal carcinoma: a case-control study among U.S. whites. J Natl Cancer Inst. 1992;84(8):619–22.

    CAS  PubMed  Google Scholar 

  13. Bray F, Haugen M, Moger TA, Tretli S, Aalen OO, Grotmol T. Age-incidence curves of nasopharyngeal carcinoma worldwide: bimodality in low-risk populations and aetiologic implications. Cancer Epidemiol Biomarkers Prev. 2008;17(9):2356–65.

    PubMed  Google Scholar 

  14. Cannon T, Zanation AM, Lai V, Weissler MC. Nasopharyngeal carcinoma in young patients: a systematic review of racial demographics. Laryngoscope. 2006;116(6):1021–6.

    PubMed  Google Scholar 

  15. Richey LM, Olshan AF, George J, Shores CG, Zanation AM, Cannon T, et al. Incidence and survival rates for young blacks with nasopharyngeal carcinoma in the United States. Arch Otolaryngol Head Neck Surg. 2006;132(10):1035–40.

    PubMed  Google Scholar 

  16. Sultan I, Casanova M, Ferrari A, Rihani R, Rodriguez-Galindo C. Differential features of nasopharyngeal carcinoma in children and adults: a SEER study. Pediatr Blood Cancer. 2010;55(2):279–84.

    PubMed  Google Scholar 

  17. Stambuk HE, Patel SG, Mosier KM, Wolden SL, Holodny AI. Nasopharyngeal carcinoma: recognizing the radiographic features in children. Am J Neuroradiol. 2005;26(6):1575–9. PubMed PMID: 15956532.

    PubMed  Google Scholar 

  18. Yabuuchi H, Fukuya T, Murayama S, Sakai S, Okamura J, Fukuda T, et al. CT and MR features of nasopharyngeal carcinoma in children and young adults. Clin Radiol. 2002;57(3):205–10. doi: 10.1053/crad.2001.0731, PubMed PMID: 11952316.

    PubMed  Google Scholar 

  19. Sham JS, Wei WI, Kwan WH, Chan CW, Choi PH, Choy D. Fiberoptic endoscopic examination and biopsy in determining the extent of nasopharyngeal carcinoma. Cancer. 1989;64(9):1838–42.

    CAS  PubMed  Google Scholar 

  20. Shanmugaratnam K, Chan SH, de-The G, Goh JE, Khor TH, Simons MJ, et al. Histopathology of nasopharyngeal carcinoma: correlations with epidemiology, survival rates and other biological characteristics. Cancer. 1979;44(3):1029–44.

    CAS  PubMed  Google Scholar 

  21. Brown JJ, Berry GJ, Moretto J, Keating WF, Fee Jr WE. Validity of clinic biopsy specimens in classifying histopathologic characteristics of recurrent nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 1997;123(9):950–5.

    CAS  PubMed  Google Scholar 

  22. Cheung F, Chan O, Ng WT, Chan L, Lee A, Pang SW. The prognostic value of histological typing in nasopharyngeal carcinoma. Oral Oncol. 2012;48(5):429–33.

    PubMed  Google Scholar 

  23. Prathap K, Looi LM, Prasad U. Localized amyloidosis in nasopharyngeal carcinoma. Histopathology. 1984;8(1):27–34.

    CAS  PubMed  Google Scholar 

  24. Chen CL, Su IJ, Hsu MM, Hsu HC. Granulomatous nasopharyngeal carcinoma: with emphasis on difficulty in diagnosis and favorable outcome. J Formos Med Assoc. 1991;90(4):353–6.

    CAS  PubMed  Google Scholar 

  25. Zong YS, Lin H, Choy DT, Sham JS, Wei W, Chan KH, et al. Nasopharyngeal carcinoma and lymphoinfiltration. Oncology. 1991;48(4):290–6.

    CAS  PubMed  Google Scholar 

  26. Wan SK, Chan JK, Lau WH, Yip TT. Basaloid-squamous carcinoma of the nasopharynx. An Epstein-Barr virus-associated neoplasm compared with morphologically identical tumors occurring in other sites. Cancer. 1995;76(10):1689–93.

    CAS  PubMed  Google Scholar 

  27. Roy C, Choudhury KB, Basu S. Basaloid squamous cell carcinoma of nasopharynx: an extremely rare variety of tumour of nasopharynx. J Indian Med Assoc. 2011;109(5):343–4.

    PubMed  Google Scholar 

  28. Franchi A, Moroni M, Massi D, Paglierani M, Santucci M. Sinonasal undifferentiated carcinoma, nasopharyngeal-type undifferentiated carcinoma, and keratinizing and nonkeratinizing squamous cell carcinoma express different cytokeratin patterns. Am J Surg Pathol. 2002;26(12):1597–604.

    PubMed  Google Scholar 

  29. Guo C, Pan ZG, Li DJ, Yun JP, Zheng MZ, Hu ZY, et al. The expression of p63 is associated with the differential stage in nasopharyngeal carcinoma and EBV infection. J Transl Med. 2006;4:23.

    PubMed Central  PubMed  Google Scholar 

  30. Friedrich RE, Bartel-Friedrich S, Lobeck H, Niedobitek G, Arps H. Epstein-Barr virus DNA, intermediate filaments and epithelial membrane antigen in nasopharyngeal carcinoma. Anticancer Res. 2000;20(6D):4909–16.

    CAS  PubMed  Google Scholar 

  31. Hsiao JR, Jin YT, Tsai ST. EBER1 in situ hybridization as an adjuvant for diagnosis of recurrent nasopharyngeal carcinoma. Anticancer Res. 1998;18(6B):4585–9.

    CAS  PubMed  Google Scholar 

  32. Hwang TZ, Jin YT, Tsai ST. EBER in situ hybridization differentiates carcinomas originating from the sinonasal region and the nasopharynx. Anticancer Res. 1998;18(6B):4581–4.

    CAS  PubMed  Google Scholar 

  33. Inoue H, Sato Y, Tsuchiya B, Nagai H, Takahashi H, Kameya T. Expression of Epstein-Barr virus-encoded small nuclear RNA 1 in Japanese nasopharyngeal carcinomas. Acta Otolaryngol Suppl. 2002;547:113–7.

    PubMed  Google Scholar 

  34. Sheu JJ, Lee CH, Ko JY, Tsao GS, Wu CC, Fang CY, et al. Chromosome 3p12.3-p14.2 and 3q26.2-q26.32 are genomic markers for prognosis of advanced nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2009;18(10):2709–16.

    CAS  PubMed  Google Scholar 

  35. Zhou W, Feng X, Li H, Wang L, Zhu B, Liu W, et al. Inactivation of LARS2, located at the commonly deleted region 3p21.3, by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma. Acta Biochim Biophys Sin. 2009;41(1):54-62.

    Google Scholar 

  36. Yi HM, Li H, Peng D, Zhang HJ, Wang L, Zhao M, et al. Genetic and epigenetic alterations of LTF at 3p21.3 in nasopharyngeal carcinoma. Oncol Res. 2006;16(6):261–72.

    CAS  PubMed  Google Scholar 

  37. Zeng Z, Zhou Y, Zhang W, Li X, Xiong W, Liu H, et al. Family-based association analysis validates chromosome 3p21 as a putative nasopharyngeal carcinoma susceptibility locus. Genet Med. 2006;8(3):156–60.

    CAS  PubMed  Google Scholar 

  38. Jenkin RD, Anderson JR, Jereb B, Thompson JC, Pyesmany A, Wara WM, et al. Nasopharyngeal carcinoma–a retrospective review of patients less than thirty years of age: a report of Children’s Cancer Study Group. Cancer. 1981;47(2):360–6.

    CAS  PubMed  Google Scholar 

  39. Lombardi F, Gasparini M, Gianni C, De Marie M, Molinari R, Pilotti S. Nasopharyngeal carcinoma in childhood. Med Pediatr Oncol. 1982;10(3):243–50.

    CAS  PubMed  Google Scholar 

  40. Ozyar E, Selek U, Laskar S, Uzel O, Anacak Y, Ben-Arush M, et al. Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: a Rare Cancer Network study. Radiother Oncol. 2006;81(1):39–46.

    PubMed  Google Scholar 

  41. Chen CL, Hsu MM. Second primary epithelial malignancy of nasopharynx and nasal cavity after successful curative radiation therapy of nasopharyngeal carcinoma. Hum Pathol. 2000;31(2):227–32.

    CAS  PubMed  Google Scholar 

  42. Khan A, Smellie J, Nutting C, Harrington K, Newbold K. Familial nonmedullary thyroid cancer: a review of the genetics. Thyroid. 2010;20(7):795–801. Epub 2010/05/15. doi: 10.1089/thy.2009.0216, PubMed PMID: 20465534.

    CAS  PubMed  Google Scholar 

  43. French CA, Miyoshi I, Kubonishi I, Grier HE, Perez-Atayde AR, Fletcher JA. BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. Cancer Res. 2003;63(2):304–7.

    CAS  PubMed  Google Scholar 

  44. French CA, Kutok JL, Faquin WC, Toretsky JA, Antonescu CR, Griffin CA, et al. Midline carcinoma of children and young adults with NUT rearrangement. J Clin Oncol. 2004;22(20):4135–9.

    CAS  PubMed  Google Scholar 

  45. Stelow EB. A review of NUT midline carcinoma. Head Neck Pathol. 2011;5(1):31–5.

    PubMed Central  PubMed  Google Scholar 

  46. Bauer DE, Mitchell CM, Strait KM, Lathan CS, Stelow EB, Luer SC, et al. Clinicopathologic features and long-term outcomes of NUT midline carcinoma. Clin Cancer Res. 2012;18(20):5773–9.

    PubMed Central  PubMed  Google Scholar 

  47. den Bakker MA, Beverloo BH, van den Heuvel-Eibrink MM, Meeuwis CA, Tan LM, Johnson LA, et al. NUT midline carcinoma of the parotid gland with mesenchymal differentiation. Am J Surg Pathol. 2009;33(8):1253–8.

    Google Scholar 

  48. Shehata BM, Steelman CK, Abramowsky CR, Olson TA, French CA, Saxe DF, et al. NUT midline carcinoma in a newborn with multiorgan disseminated tumor and a 2-year-old with a pancreatic/hepatic primary. Pediatr Dev Pathol. 2010;13(6):481–5.

    PubMed  Google Scholar 

  49. Ziai J, French CA, Zambrano E. NUT gene rearrangement in a poorly-differentiated carcinoma of the submandibular gland. Head Neck Pathol. 2010;4(2):163–8.

    PubMed Central  PubMed  Google Scholar 

  50. Tanaka M, Kato K, Gomi K, Yoshida M, Niwa T, Aida N, et al. NUT midline carcinoma: report of 2 cases suggestive of pulmonary origin. Am J Surg Pathol. 2012;36(3):381–8.

    PubMed  Google Scholar 

  51. French CA. Pathogenesis of NUT midline carcinoma. Annu Rev Pathol. 2012;7:247–65.

    CAS  PubMed  Google Scholar 

  52. Polsani A, Braithwaite KA, Alazraki AL, Abramowsky C, Shehata BM. NUT midline carcinoma: an imaging case series and review of literature. Pediatr Radiol. 2012;42(2):205–10. doi: 10.1007/s00247-011-2272-3, PubMed PMID: 22033856.

    PubMed  Google Scholar 

  53. Nelson BA, Lee EY, French CA, Bauer DE, Vargas SO. BRD4-NUT carcinoma of the mediastinum in a pediatric patient: multidetector computed tomography imaging findings. J Thorac Imaging. 2010;25(3):W93–6. doi: 10.1097/RTI.0b013e3181b5d84d, PubMed PMID: 20395873.

    PubMed  Google Scholar 

  54. Huh WW, Holsinger FC, Levy A, Palla FS, Anderson PM. Osteosarcoma of the jaw in children and young adults. Head Neck. 2012;34(7):981–4. Epub 2011/08/20. doi: 10.1002/hed.21850, PubMed PMID: 21853501.

    PubMed  Google Scholar 

  55. French CA, Ramirez CL, Kolmakova J, Hickman TT, Cameron MJ, Thyne ME, et al. BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells. Oncogene. 2008;27(15):2237–42.

    CAS  PubMed  Google Scholar 

  56. Fang W, French CA, Cameron MJ, Han Y, Liu H. Clinicopathological significance of NUT rearrangements in poorly differentiated malignant tumors of the upper respiratory tract. Int J Surg Pathol. 2013;21(2):102–10.

    CAS  PubMed  Google Scholar 

  57. Haack H, Johnson LA, Fry CJ, Crosby K, Polakiewicz RD, Stelow EB, et al. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am J Surg Pathol. 2009;33(7):984–91.

    PubMed Central  PubMed  Google Scholar 

  58. Evans AG, French CA, Cameron MJ, Fletcher CD, Jackman DM, Lathan CS, et al. Pathologic characteristics of NUT midline carcinoma arising in the mediastinum. Am J Surg Pathol. 2012;36(8):1222–7.

    PubMed Central  PubMed  Google Scholar 

  59. Broich G, Pagliari A, Ottaviani F. Esthesioneuroblastoma: a general review of the cases published since the discovery of the tumour in 1924. Anticancer Res. 1997;17(4A):2683–706.

    CAS  PubMed  Google Scholar 

  60. Turner JH, Reh DD. Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data. Head Neck. 2012;34(6):877–85.

    PubMed  Google Scholar 

  61. Jethanamest D, Morris LG, Sikora AG, Kutler DI. Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors. Arch Otolaryngol Head Neck Surg. 2007;133(3):276–80.

    PubMed  Google Scholar 

  62. Kumar M, Fallon RJ, Hill JS, Davis MM. Esthesioneuroblastoma in children. J Pediatr Hematol Oncol. 2002;24(6):482–7.

    PubMed  Google Scholar 

  63. Cohen ZR, Marmor E, Fuller GN, DeMonte F. Misdiagnosis of olfactory neuroblastoma. Neurosurg Focus. 2002;12(5):e3.

    PubMed  Google Scholar 

  64. Hamilton AE, Rubinstein LJ, Poole GJ. Primary intracranial esthesioneuroblastoma, (olfactory neuroblastoma). J Neurosurg. 1973;38(5):548–56.

    CAS  PubMed  Google Scholar 

  65. Josephs L, Jones L, Marenette L, McKeever P. Cushing’s syndrome: an unusual presentation of olfactory neuroblastoma. Skull Base. 2008;18(1):73–6.

    PubMed Central  PubMed  Google Scholar 

  66. Plasencia YL, Cortes MB, Arencibia DM, Damaso TM, Contreras IL, Pino AO, et al. Esthesioneuroblastoma recurrence presenting as a syndrome of inappropriate antidiuretic hormone secretion. Head Neck. 2006;28(12):1142–6.

    PubMed  Google Scholar 

  67. Bisogno G, Soloni P, Conte M, Podda M, Ferrari A, Garaventa A, et al. Esthesioneuroblastoma in pediatric and adolescent age. A report from the TREP project in cooperation with the Italian Neuroblastoma and Soft Tissue Sarcoma Committees. BMC Cancer. 2012;12(117):1471–2407.

    Google Scholar 

  68. Wang SL, Li SH, Chen WT, Chai CY. Absence of Epstein-Barr virus in olfactory neuroblastoma. Pathology. 2007;39(6):565–6.

    PubMed  Google Scholar 

  69. Som PM, Lidov M, Brandwein M, Catalano P, Biller HF. Sinonasal esthesioneuroblastoma with intracranial extension: marginal tumor cysts as a diagnostic MR finding. Am J Neuroradiol. 1994;15(7):1259–62. PubMed PMID: 7976934.

    CAS  PubMed  Google Scholar 

  70. Faragalla H, Weinreb I. Olfactory neuroblastoma: a review and update. Adv Anat Pathol. 2009;16(5):322–31.

    CAS  PubMed  Google Scholar 

  71. Gaudin PB, Rosai J. Florid vascular proliferation associated with neural and neuroendocrine neoplasms. A diagnostic clue and potential pitfall. Am J Surg Pathol. 1995;19(6):642–52.

    CAS  PubMed  Google Scholar 

  72. Bates T, Plessis DD, Polvikoski T, Sloan P, McQueen A, Meikle D, et al. Ganglioneuroblastic transformation in olfactory neuroblastoma. Head Neck Pathol. 2012;6(1):150–5.

    PubMed Central  PubMed  Google Scholar 

  73. Stones DK, Jansen JC, Griessel D. Sialoblastoma and hepatoblastoma in a newborn infant. Pediatr Blood Cancer. 2009;52(7):883–5.

    CAS  PubMed  Google Scholar 

  74. Wooff JC, Weinreb I, Perez-Ordonez B, Magee JF, Bullock MJ. Calretinin staining facilitates differentiation of olfactory neuroblastoma from other small round blue cell tumors in the sinonasal tract. Am J Surg Pathol. 2011;35(12):1786–93.

    PubMed  Google Scholar 

  75. Frierson Jr HF, Ross GW, Mills SE, Frankfurter A. Olfactory neuroblastoma. Additional immunohistochemical characterization. Am J Clin Pathol. 1990;94(5):547–53.

    PubMed  Google Scholar 

  76. Bourne TD, Bellizzi AM, Stelow EB, Loy AH, Levine PA, Wick MR, et al. p63 Expression in olfactory neuroblastoma and other small cell tumors of the sinonasal tract. Am J Clin Pathol. 2008;130(2):213–8.

    PubMed  Google Scholar 

  77. Holland H, Koschny R, Krupp W, Meixensberger J, Bauer M, Kirsten H, et al. Comprehensive cytogenetic characterization of an esthesioneuroblastoma. Cancer Genet Cytogenet. 2007;173(2):89–96.

    CAS  PubMed  Google Scholar 

  78. Guled M, Myllykangas S, Frierson Jr HF, Mills SE, Knuutila S, Stelow EB. Array comparative genomic hybridization analysis of olfactory neuroblastoma. Mod Pathol. 2008;21(6):770–8.

    CAS  PubMed  Google Scholar 

  79. Weiss GJ, Liang WS, Izatt T, Arora S, Cherni I, Raju RN, et al. Paired tumor and normal whole genome sequencing of metastatic olfactory neuroblastoma. PLoS One. 2012;7(5):23.

    Google Scholar 

  80. Argani P, Perez-Ordonez B, Xiao H, Caruana SM, Huvos AG, Ladanyi M. Olfactory neuroblastoma is not related to the Ewing family of tumors: absence of EWS/FLI1 gene fusion and MIC2 expression. Am J Surg Pathol. 1998;22(4):391–8.

    CAS  PubMed  Google Scholar 

  81. Mezzelani A, Tornielli S, Minoletti F, Pierotti MA, Sozzi G, Pilotti S. Esthesioneuroblastoma is not a member of the primitive peripheral neuroectodermal tumour-Ewing’s group. Br J Cancer. 1999;81(4):586–91.

    PubMed Central  CAS  PubMed  Google Scholar 

  82. Kumar S, Perlman E, Pack S, Davis M, Zhang H, Meltzer P, et al. Absence of EWS/FLI1 fusion in olfactory neuroblastomas indicates these tumors do not belong to the Ewing’s sarcoma family. Hum Pathol. 1999;30(11):1356–60.

    CAS  PubMed  Google Scholar 

  83. Koka VN, Julieron M, Bourhis J, Janot F, Le Ridant AM, Marandas P, et al. Aesthesioneuroblastoma. J Laryngol Otol. 1998;112(7):628–33.

    CAS  PubMed  Google Scholar 

  84. Ferlito A, Rinaldo A, Rhys-Evans PH. Contemporary clinical commentary: esthesioneuroblastoma: an update on management of the neck. Laryngoscope. 2003;113(11):1935–8.

    PubMed  Google Scholar 

  85. Demiroz C, Gutfeld O, Aboziada M, Brown D, Marentette LJ, Eisbruch A. Esthesioneuroblastoma: is there a need for elective neck treatment? Int J Radiat Oncol Biol Phys. 2011;81(4):15.

    Google Scholar 

  86. Ahmed AA, Tsokos M. Sinonasal rhabdomyosarcoma in children and young adults. Int J Surg Pathol. 2007;15(2):160–5.

    PubMed  Google Scholar 

  87. Turner JH, Richmon JD. Head and neck rhabdomyosarcoma: a critical analysis of population-based incidence and survival data. Otolaryngol Head Neck Surg. 2011;145(6):967–73.

    PubMed  Google Scholar 

  88. Koivunen P, Suutala L, Schorsch I, Jokinen K, Alho OP. Malignant epithelial salivary gland tumors in northern Finland: incidence and clinical characteristics. Eur Arch Otorhinolaryngol. 2002;259(3):146–9.

    PubMed  Google Scholar 

  89. Pinkston JA, Cole P. Incidence rates of salivary gland tumors: results from a population-based study. Otolaryngol Head Neck Surg. 1999;120(6):834–40.

    CAS  PubMed  Google Scholar 

  90. Eveson JW, Cawson RA. Salivary gland tumours. A review of 2410 cases with particular reference to histological types, site, age and sex distribution. J Pathol. 1985;146(1):51–8.

    CAS  PubMed  Google Scholar 

  91. Fitzpatrick PJ, Theriault C. Malignant salivary gland tumors. Int J Radiat Oncol Biol Phys. 1986;12(10):1743–7.

    CAS  PubMed  Google Scholar 

  92. Sultan I, Rodriguez-Galindo C, Al-Sharabati S, Guzzo M, Casanova M, Ferrari A. Salivary gland carcinomas in children and adolescents: a population-based study, with comparison to adult cases. Head Neck. 2011;33(10):1476–81.

    PubMed  Google Scholar 

  93. Baker SR, Malone B. Salivary gland malignancies in children. Cancer. 1985;55(8):1730–6.

    CAS  PubMed  Google Scholar 

  94. Vedrine PO, Coffinet L, Temam S, Montagne K, Lapeyre M, Oberlin O, et al. Mucoepidermoid carcinoma of salivary glands in the pediatric age group: 18 clinical cases, including 11 second malignant neoplasms. Head Neck. 2006;28(9):827–33.

    PubMed  Google Scholar 

  95. Brandwein MS, Ivanov K, Wallace DI, Hille JJ, Wang B, Fahmy A, et al. Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading. Am J Surg Pathol. 2001;25(7):835–45.

    CAS  PubMed  Google Scholar 

  96. Rahbar R, Grimmer JF, Vargas SO, Robson CD, Mack JW, Perez-Atayde AR, et al. Mucoepidermoid carcinoma of the parotid gland in children: a 10-year experience. Arch Otolaryngol Head Neck Surg. 2006;132(4):375–80. doi: 10.1001/archotol.132.4.375, PubMed PMID: 16618905.

    PubMed  Google Scholar 

  97. Som PM, Biller HF. High-grade malignancies of the parotid gland: identification with MR imaging. Radiology. 1989;173(3):823–6. doi: 10.1148/radiology.173.3.2813793, PubMed PMID: 2813793.

    CAS  PubMed  Google Scholar 

  98. Bell D, El-Naggar AK. Molecular heterogeneity in mucoepidermoid carcinoma: conceptual and practical implications. Head Neck Pathol. 2013;7(1):23–7.

    PubMed Central  PubMed  Google Scholar 

  99. Sams RN, Gnepp DR. P63 expression can be used in differential diagnosis of salivary gland acinic cell and mucoepidermoid carcinomas. Head Neck Pathol. 2013;7(1):64–8.

    PubMed Central  PubMed  Google Scholar 

  100. Ellis GL. What’s new in the AFIP fascicle on salivary gland tumors: a few highlights from the 4th Series Atlas. Head Neck Pathol. 2009;3(3):225–30.

    PubMed Central  PubMed  Google Scholar 

  101. Dehner LP, Valbuena L, Perez-Atayde A, Reddick RL, Askin FB, Rosai J. Salivary gland anlage tumor (“congenital pleomorphic adenoma”). A clinicopathologic, immunohistochemical and ultrastructural study of nine cases. Am J Surg Pathol. 1994;18(1):25–36.

    CAS  PubMed  Google Scholar 

  102. Siddiqi SH, Solomon MP, Haller JO. Sialoblastoma and hepatoblastoma in a neonate. Pediatr Radiol. 2000;30(5):349–51.

    CAS  PubMed  Google Scholar 

  103. Cheng YK, Chu WC, Law LW, Ting YH, Leung TY. A fetus with a huge neck mass and a large abdominal circumference–a rare case of sialoblastoma and hepatoblastoma. Prenat Diagn. 2012;32(9):915–7. Epub 2012/06/20. doi: 10.1002/pd.3927, PubMed PMID: 22711473.

    PubMed  Google Scholar 

  104. Yekeler E, Dursun M, Gun F, Kilincaslan H, Ucar A, Genchellac H, et al. Sialoblastoma: MRI findings. Pediatr Radiol. 2004;34(12):1005–7. doi: 10.1007/s00247-004-1286-5, PubMed PMID: 15278323.

    PubMed  Google Scholar 

  105. Williams SB, Ellis GL, Warnock GR. Sialoblastoma: a clinicopathologic and immunohistochemical study of 7 cases. Ann Diagn Pathol. 2006;10(6):320–6.

    PubMed  Google Scholar 

  106. Mertens F, Wahlberg P, Domanski HA. Clonal chromosome aberrations in a sialoblastoma. Cancer Genet Cytogenet. 2009;189(1):68–9. doi: 10.1016/j.cancergencyto.2008.10.005, Epub 2009/01/27 S0165-4608(08)00582-7 [pii]. PubMed PMID: 19167616.

    CAS  PubMed  Google Scholar 

  107. Brandwein M, Al-Naeif NS, Manwani D, Som P, Goldfeder L, Rothschild M, et al. Sialoblastoma: clinicopathological/immunohistochemical study. Am J Surg Pathol. 1999;23(3):342–8.

    CAS  PubMed  Google Scholar 

  108. Draganov P, Todorov S, Todorov I, Karchev T, Kalvatchev Z. Identification of HPV DNA in patients with juvenile-onset recurrent respiratory papillomatosis using SYBR Green real-time PCR. Int J Pediatr Otorhinolaryngol. 2006;70(3):469–73. Epub 2005/09/03. doi: 10.1016/j.ijporl.2005.07.018, PubMed PMID: 16137771.

    PubMed  Google Scholar 

  109. Somers GR, Tabrizi SN, Borg AJ, Garland SM, Chow CW. Juvenile laryngeal papillomatosis in a pediatric population: a clinicopathologic study. Pediatr Pathol Lab Med. 1997;17(1):53–64. Epub 1997/01/01. PubMed PMID: 9050060.

    CAS  PubMed  Google Scholar 

  110. Gelinas JF, Manoukian J, Cote A. Lung involvement in juvenile onset recurrent respiratory papillomatosis: a systematic review of the literature. Int J Pediatr Otorhinolaryngol. 2008;72(4):433–52. Epub 2008/02/19. doi: 10.1016/j.ijporl.2007.12.003, PubMed PMID: 18281102.

    PubMed  Google Scholar 

  111. Schlecht NF, Burk RD, Nucci-Sack A, Shankar V, Peake K, Lorde-Rollins E, et al. Cervical, anal and oral HPV in an adolescent inner-city health clinic providing free vaccinations. PLoS One. 2012;7(5):e37419. Epub 2012/05/25. doi: 10.1371/journal.pone.0037419, PubMed PMID: 22624027. PubMed Central PMCID: PMC3356254.

    PubMed Central  CAS  PubMed  Google Scholar 

  112. El-Mofty SK, Lu DW. Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol. 2003;27(11):1463–70. Epub 2003/10/25. PubMed PMID: 14576481.

    PubMed  Google Scholar 

  113. Elango KJ, Suresh A, Erode EM, Subhadradevi L, Ravindran HK, Iyer SK, et al. Role of human papilloma virus in oral tongue squamous cell carcinoma. Asian Pac J Cancer Prev. 2011;12(4):889–96. Epub 2011/07/28. PubMed PMID: 21790221.

    PubMed  Google Scholar 

  114. Aggunlu L, Erbas G. Recurrent respiratory papillomatosis with lung involvement. Diagn Interv Radiol. 2009;15(2):93–5. Epub 2009/06/12. PubMed PMID: 19517378.

    PubMed  Google Scholar 

  115. Som P, Curtin HD. Head and neck imaging. 5th ed. St. Louis: Elsevier; 2011. 3080 p.

    Google Scholar 

  116. Khoddami M, Squire J, Zielenska M, Thorner P. Melanotic neuroectodermal tumor of infancy: a molecular genetic study. Pediatr Dev Pathol. 1998;1(4):295–9. Epub 1999/08/27. PubMed PMID: 10463291.

    CAS  PubMed  Google Scholar 

  117. Kapadia SB, Frisman DM, Hitchcock CL, Ellis GL, Popek EJ. Melanotic neuroectodermal tumor of infancy. Clinicopathological, immunohistochemical, and flow cytometric study. Am J Surg Pathol. 1993;17(6):566–73.

    CAS  PubMed  Google Scholar 

  118. George JC, Edwards MK, Jakacki RI, Kho-Duffin J. Melanotic neuroectodermal tumor of infancy. Am J Neuroradiol. 1995;16(6):1273–5. Epub 1995/06/01. PubMed PMID: 7677023.

    CAS  PubMed  Google Scholar 

  119. Mirich DR, Blaser SI, Harwood-Nash DC, Armstrong DC, Becker LE, Posnick JC. Melanotic neuroectodermal tumor of infancy: clinical, radiologic, and pathologic findings in five cases. Am J Neuroradiol. 1991;12(4):689–97. Epub 1991/07/01. PubMed PMID: 1652883.

    CAS  PubMed  Google Scholar 

  120. Haque S, McCarville MB, Sebire N, McHugh K. Melanotic neuroectodermal tumour of infancy: CT and MR findings. Pediatr Radiol. 2012;42(6):699–705. Epub 2012/03/21. doi: 10.1007/s00247-011-2339-1, PubMed PMID: 22430481. PubMed Central PMCID: PMC3526662.

    PubMed Central  PubMed  Google Scholar 

  121. Walterhouse DO, Pappo AS, Baker KS, Parham DM, Anderson JR, Donaldson SS, et al. Rhabdomyosarcoma of the parotid region occurring in childhood and adolescence. A report from the Intergroup Rhabdomyosarcoma Study Group. Cancer. 2001;92(12):3135–46. Epub 2001/12/26. PubMed PMID: 11753993.

    CAS  PubMed  Google Scholar 

  122. Ellison DA, Adada B, Qualman SJ, Parham DM. Melanotic neuroectodermal tumor of infancy: report of a case with myogenic differentiation. Pediatr Dev Pathol. 2007;10(2):157–60. Epub 2007/03/24. doi: 10.2350/06-07-0138.1, PubMed PMID: 17378694.

    PubMed  Google Scholar 

  123. Barrett AW, Morgan M, Ramsay AD, Farthing PM, Newman L, Speight PM. A clinicopathologic and immunohistochemical analysis of melanotic neuroectodermal tumor of infancy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93(6):688–98. Epub 2002/07/27. doi: S107921040200032X [pii]. PubMed PMID: 12142876.

    CAS  PubMed  Google Scholar 

  124. Parham DM. Neuroectodermal and neuroendocrine tumors principally seen in children. Am J Clin Pathol. 2001;115(Suppl):S113–28. Epub 2002/05/08. PubMed PMID: 11993686.

    PubMed  Google Scholar 

  125. Burkitt DP. The discovery of Burkitt’s lymphoma. Cancer. 1983;51(10):1777–86. Epub 1983/05/15. PubMed PMID: 6299496.

    CAS  PubMed  Google Scholar 

  126. Thorley-Lawson DA, Allday MJ. The curious case of the tumour virus: 50 years of Burkitt’s lymphoma. Nat Rev Microbiol. 2008;6(12):913–24. Epub 2008/11/15. doi: 10.1038/nrmicro2015, PubMed PMID: 19008891.

    CAS  PubMed  Google Scholar 

  127. Bilodeau E, Galambos C, Yeung A, Potluri A, Collins B. Sporadic Burkitt lymphoma of the jaw: case report and review of the literature. Quintessence Int. 2012;43(4):333–6. Epub 2012/04/26. PubMed PMID: 22532948.

    PubMed  Google Scholar 

  128. Ishii E, Eguchi M, Matsuzaki A, Zaizen Y, Yoshidomi S, Kimura N, et al. Granulocytic sarcoma in infant with MLL rearrangement preceding acute monoblastic leukemia with t(10;11)(p11;q23). Leukemia. 1995;9(11):1970–4. Epub 1995/11/01. PubMed PMID: 7475292.

    CAS  PubMed  Google Scholar 

  129. Arul AS, Verma S, Ahmed S. A clinical and fine needle aspiration cytology study of gingiva in acute leukemia. Dent Res J (Isfahan). 2012;9(1):80–5. Epub 2012/03/01. doi: 10.4103/1735-3327.92954, PubMed PMID: 22363368. PubMed Central PMCID: PMC3283984.

    Google Scholar 

  130. Anavi Y, Kaplinsky C, Calderon S, Zaizov R. Head, neck, and maxillofacial childhood Burkitt's lymphoma: a retrospective analysis of 31 patients. J Oral Maxillofac Surg. 1990;48(7):708–13. PubMed PMID: 2358947.

    CAS  PubMed  Google Scholar 

  131. Valencerina Gopez E, Dauterman J, Layfield LJ. Fine-needle aspiration biopsy of alveolar rhabdomyosarcoma of the parotid: a case report and review of the literature. Diagn Cytopathol. 2001;24(4):249–52. Epub 2001/04/04. PubMed PMID: 11285621.

    CAS  PubMed  Google Scholar 

  132. De M, Banerjee A, Graham I, Dempster J. Alveolar rhabdomyosarcoma of the parotid gland. J Laryngol Otol. 2001;115(2):155–7. Epub 2001/04/26. PubMed PMID: 11320838.

    CAS  PubMed  Google Scholar 

  133. Nayak JV, Teot LA, Vyas Y, Snyderman CH, Toh EH, Deleyiannis FW. Head and neck epithelioid sarcoma in a child: diagnostic dilemma and anterolateral thigh free flap reconstruction. Int J Pediatr Otorhinolaryngol. 2008;72(5):719–24. Epub 2008/03/19. doi: 10.1016/j.ijporl.2008.01.032, PubMed PMID: 18346795.

    PubMed  Google Scholar 

  134. Kim HS, Lee HK, Weon YC, Kim HJ. Alveolar soft-part sarcoma of the head and neck: clinical and imaging features in five cases. Am J Neuroradiol. 2005;26(6):1331–5. Epub 2005/06/16. PubMed PMID: 15956492.

    PubMed  Google Scholar 

  135. Hunter BC, Devaney KO, Ferlito A, Rinaldo A. Alveolar soft part sarcoma of the head and neck region. Ann Otol Rhinol Laryngol. 1998;107(9 Pt 1):810–4. Epub 1998/09/28. PubMed PMID: 9749554.

    CAS  PubMed  Google Scholar 

  136. Smith DM, Mahmoud HH, Jenkins 3rd JJ, Rao B, Hopkins KP, Parham DM. Myofibrosarcoma of the head and neck in children. Pediatr Pathol Lab Med. 1995;15(3):403–18. Epub 1995/05/01. PubMed PMID: 8597827.

    CAS  PubMed  Google Scholar 

  137. Sharif MA, Mushtaq S, Mamoon N, Khadim MT, Asghar Z. Biphasic synovial sarcoma of oral cavity. J Coll Physicians Surg Pak. 2008;18(11):713–5. Epub 2008/11/06. doi: 11.2008/JCPSP.713715, PubMed PMID: 18983797.

    PubMed  Google Scholar 

  138. Wang H, Zhang J, He X, Niu Y. Synovial sarcoma in the oral and maxillofacial region: report of 4 cases and review of the literature. J Oral Maxillofac Surg. 2008;66(1):161–7. Epub 2007/12/18. doi: 10.1016/j.joms.2007.05.007, PubMed PMID: 18083434.

    PubMed  Google Scholar 

  139. Canter RJ, Qin LX, Maki RG, Brennan MF, Ladanyi M, Singer S. A synovial sarcoma-specific preoperative nomogram supports a survival benefit to ifosfamide-based chemotherapy and improves risk stratification for patients. Clin Cancer Res. 2008;14(24):8191–7. Epub 2008/12/18. doi: 10.1158/1078-0432.CCR-08-0843, PubMed PMID: 19088035. PubMed Central PMCID: PMC2779709.

    PubMed Central  CAS  PubMed  Google Scholar 

  140. Chen Y, Yang Y, Wang C, Shi Y. Adjuvant chemotherapy decreases and postpones distant metastasis in extremity stage IIB/III synovial sarcoma patients. J Surg Oncol. 2012;106(2):162–8. Epub 2012/02/03. doi: 10.1002/jso.23061, PubMed PMID: 22297839.

    PubMed  Google Scholar 

  141. Nissanka EH, Amaratunge EA, Tilakaratne WM. Clinicopathological analysis of osteosarcoma of jaw bones. Oral Dis. 2007;13(1):82–7. Epub 2007/01/24. doi: 10.1111/j.1601-0825.2006.01251.x, PubMed PMID: 17241435.

    CAS  PubMed  Google Scholar 

  142. Lee YY, Van Tassel P, Nauert C, Raymond AK, Edeiken J. Craniofacial osteosarcomas: plain film, CT, and MR findings in 46 cases. Am J Roentgenol. 1988;150(6):1397–402. doi: 10.2214/ajr.150.6.1397, PubMed PMID: 3259385.

    CAS  Google Scholar 

  143. Gadwal SR, Gannon FH, Fanburg-Smith JC, Becoskie EM, Thompson LD. Primary osteosarcoma of the head and neck in pediatric patients: a clinicopathologic study of 22 cases with a review of the literature. Cancer. 2001;91(3):598–605. PubMed PMID: 11169944.

    CAS  PubMed  Google Scholar 

  144. Ma CY, Ji T, Wu YQ, Ow A. A jugulotympanic paraganglioma with craniocervical extension. Int J Oral Maxillofac Surg. 2012;41(2):221–4. Epub 2011/11/29. doi: 10.1016/j.ijom.2011.10.020, PubMed PMID: 22119569.

    CAS  PubMed  Google Scholar 

  145. Johnstone PA, Foss RD, Desilets DJ. Malignant jugulotympanic paraganglioma. Arch Pathol Lab Med. 1990;114(9):976–9. Epub 1990/09/01. PubMed PMID: 2167653.

    CAS  PubMed  Google Scholar 

  146. De Foer B, Kenis C, Vercruysse JP, Somers T, Pouillon M, Offeciers E, et al. Imaging of temporal bone tumors. Neuroimaging Clin N Am. 2009;19(3):339–66. doi: 10.1016/j.nic.2009.06.003, PubMed PMID: 19733312.

    PubMed  Google Scholar 

  147. Caldemeyer KS, Mathews VP, Azzarelli B, Smith RR. The jugular foramen: a review of anatomy, masses, and imaging characteristics. Radiographics. 1997;17(5):1123–39. doi: 10.1148/radiographics.17.5.9308106, PubMed PMID: 9308106.

    CAS  PubMed  Google Scholar 

  148. Horvath KK, Ormos J, Ribari O. Crystals in a jugulotympanic paraganglioma. Ultrastruct Pathol. 1986;10(3):257–64. Epub 1986/01/01. PubMed PMID: 3012841.

    CAS  PubMed  Google Scholar 

  149. Raney Jr RB, Lawrence Jr W, Maurer HM, Lindberg RD, Newton Jr WA, Ragab AH, et al. Rhabdomyosarcoma of the ear in childhood. A report from the Intergroup Rhabdomyosarcoma Study-I. Cancer. 1983;51(12):2356–61. Epub 1983/06/15. PubMed PMID: 6342748.

    PubMed  Google Scholar 

  150. Mena JC, Borne JA. Case 3: temporal bone rhabdomyosarcoma. Am J Roentgenol. 1998;171(3):873. 7–9, doi: 10.2214/ajr.171.3.9725346, PubMed PMID: 9725346.

    CAS  Google Scholar 

  151. Sbeity S, Abella A, Arcand P, Quintal MC, Saliba I. Temporal bone rhabdomyosarcoma in children. Int J Pediatr Otorhinolaryngol. 2007;71(5):807–14. doi: 10.1016/j.ijporl.2007.02.002, PubMed PMID: 17346806.

    CAS  PubMed  Google Scholar 

  152. Hawkins DS, Anderson JR, Paidas CN, Wharam MD, Qualman SJ, Pappo AS, et al. Improved outcome for patients with middle ear rhabdomyosarcoma: a children’s oncology group study. J Clin Oncol. 2001;19(12):3073–9. Epub 2001/06/16. PubMed PMID: 11408504.

    CAS  PubMed  Google Scholar 

  153. Desandes E, Lacour B, Belot A, Molinie F, Delafosse P, Tretarre B, et al. Cancer Incidence and Survival in Adolescents and Young Adults in France, 2000-2008. Pediatr Hematol Oncol. 2013. Epub 2013/02/01. doi: 10.3109/08880018.2012.762569. PubMed PMID: 23363314.

    Google Scholar 

  154. Holmes Jr L, Hossain J, Opara F. Pediatric thyroid carcinoma incidence and temporal trends in the USA (1973–2007): race or shifting diagnostic paradigm? ISRN Oncol. 2012;2012:906197. Epub 2012/04/25. doi: 10.5402/2012/906197, PubMed PMID: 22530151; PubMed Central PMCID: PMCPMC3317016.

    PubMed Central  PubMed  Google Scholar 

  155. Kazakov VS, Demidchik EP, Astakhova LN. Thyroid cancer after Chernobyl. Nature. 1992;359(6390):21. Epub 1992/09/03. doi: 10.1038/359021a0, PubMed PMID: 1522879.

    CAS  PubMed  Google Scholar 

  156. Baverstock KF. Thyroid cancer in children in Belarus after Chernobyl. World Health Stat Q. 1993;46(3):204–8. Epub 1993/01/01. PubMed PMID: 8017079.

    CAS  PubMed  Google Scholar 

  157. Socolow EL, Hashizume A, Neriishi S, Niitani R. Thyroid carcinoma in man after exposure to ionizing radiation. A summary of the findings in Hiroshima and Nagasaki. N Engl J Med. 1963;268:406–10. Epub 1963/02/21. doi: 10.1056/nejm196302212680803, PubMed PMID: 13989805.

    CAS  PubMed  Google Scholar 

  158. Albright EC, Allday RW. Thyroid carcinoma after radiation therapy for adolescent acne vulgaris. JAMA. 1967;199(4):280–1. Epub 1967/01/23. PubMed PMID: 4224873.

    CAS  PubMed  Google Scholar 

  159. Refetoff S, Harrison J, Karanfilski BT, Kaplan EL, De Groot LJ, Bekerman C. Continuing occurrence of thyroid carcinoma after irradiation to the neck in infancy and childhood. N Engl J Med. 1975;292(4):171–5. Epub 1975/01/23. doi: 10.1056/nejm197501232920402, PubMed PMID: 122783.

    CAS  PubMed  Google Scholar 

  160. Weshler Z, Krasnokuki D, Peshin Y, Biran S. Thyroid carcinoma induced by irradiation for Hodgkin’s disease. Report of a case. Acta Radiol Oncol Radiat Phys Biol. 1978;17(5):383–6. Epub 1978/01/01. PubMed PMID: 726946.

    CAS  PubMed  Google Scholar 

  161. McDougall IR, Coleman CN, Burke JS, Saunders W, Kaplan HS. Thyroid carcinoma after high-dose external radiotherapy for Hodgkin’s disease: report of three cases. Cancer. 1980;45(8):2056–60. Epub 1980/04/15. PubMed PMID: 7370951.

    CAS  PubMed  Google Scholar 

  162. Mauras N, Zimmerman D, Goellner JR. Hashimoto thyroiditis associated with thyroid cancer in adolescent patients. J Pediatr. 1985;106(6):895–8. Epub 1985/06/01. PubMed PMID: 3839014.

    CAS  PubMed  Google Scholar 

  163. Pacini F, Mariotti S, Formica N, Elisei R, Anelli S, Capotorti E, et al. Thyroid autoantibodies in thyroid cancer: incidence and relationship with tumour outcome. Acta Endocrinol (Copenh). 1988;119(3):373–80. Epub 1988/11/01. PubMed PMID: 3188810.

    CAS  Google Scholar 

  164. Okayasu I, Fujiwara M, Hara Y, Tanaka Y, Rose NR. Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans. Cancer. 1995;76(11):2312–8.

    CAS  PubMed  Google Scholar 

  165. Ni Y, He X, Chen J, Moline J, Mester J, Orloff MS, et al. Germline SDHx variants modify breast and thyroid cancer risks in Cowden and Cowden-like syndrome via FAD/NAD-dependant destabilization of p53. Hum Mol Genet. 2012;21(2):300–10. Epub 2011/10/08. doi: 10.1093/hmg/ddr459, PubMed PMID: 21979946; PubMed Central PMCID: PMCPMC3276278.

    PubMed Central  CAS  PubMed  Google Scholar 

  166. Moses W, Weng J, Kebebew E. Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer. Thyroid. 2011;21(4):367–71. Epub 2010/12/31. doi: 10.1089/thy.2010.0256, PubMed PMID: 21190444; PubMed Central PMCID: PMCPMC3070337.

    PubMed Central  PubMed  Google Scholar 

  167. Mills SE, Allen Jr MS. Congenital occult papillary carcinoma of the thyroid gland. Hum Pathol. 1986;17(11):1179–81. Epub 1986/11/01. PubMed PMID: 3770736.

    CAS  PubMed  Google Scholar 

  168. Shapiro SJ, Friedman NB, Perzik SL, Catz B. Incidence of thyroid carcinoma in Graves’ disease. Cancer. 1970;26(6):1261–70. Epub 1970/12/01. PubMed PMID: 5536634.

    CAS  PubMed  Google Scholar 

  169. Kraimps JL, Bouin-Pineau MH, Mathonnet M, De Calan L, Ronceray J, Visset J, et al. Multicentre study of thyroid nodules in patients with Graves’ disease. Br J Surg. 2000;87(8):1111–3. Epub 2000/08/10. doi: 10.1046/j.1365-2168.2000.01504.x, PubMed PMID: 10931060.

    CAS  PubMed  Google Scholar 

  170. Cibas ES, Ali SZ. The Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol. 2009;132(5):658–65. Epub 2009/10/23. doi: 10.1309/ajcpphlwmi3jv4la, PubMed PMID: 19846805.

    PubMed  Google Scholar 

  171. Monaco SE, Pantanowitz L, Khalbuss WE, Benkovich VA, Ozolek J, Nikiforova MN, et al. Cytomorphological and molecular genetic findings in pediatric thyroid fine-needle aspiration. Cancer Cytopathol. 2012;120(5):342–50. Epub 2012/05/19. doi: 10.1002/cncy.21199, PubMed PMID: 22605559.

    PubMed  Google Scholar 

  172. Loevner LA, Kaplan SL, Cunnane ME, Moonis G. Cross-sectional imaging of the thyroid gland. Neuroimaging Clin N Am. 2008;18(3):445–61. vii, doi: 10.1016/j.nic.2008.05.001, PubMed PMID: 18656027.

    PubMed  Google Scholar 

  173. Mafee M, Valvassori GE, Becker M. Imaging of the head and neck. 2nd ed. New York: Thieme; 2004. 866 p.

    Google Scholar 

  174. Takashima S, Sone S, Takayama F, Wang Q, Kobayashi T, Horii A, et al. Papillary thyroid carcinoma: MR diagnosis of lymph node metastasis. Am J Neuroradiol. 1998;19(3):509–13. PubMed PMID: 9541309.

    CAS  PubMed  Google Scholar 

  175. Sohn SY, Choi JH, Kim NK, Joung JY, Cho YY, Park SM, et al. The impact of iodinated contrast agent administered during preoperative computed tomography scan on body iodine pool in patients with differentiated thyroid cancer preparing for radioactive iodine treatment. Thyroid. 2014. Epub 2013/12/04. doi: 10.1089/thy.2013.0238. PubMed PMID: 24295076.

    Google Scholar 

  176. Ghossein R, Asa SL, Barnes L, Chan J, et al. Protocol for the examination of specimens from patients with carcinomas of the thyroid gland. 2012. College of American Pathologists (CAP) Cancer Protocol. www.cap.org/cancerprotocol.

  177. Schrager V. Lateral aberrant thyroids. Surg Gynecol Obstet. 1906;3:465–75.

    Google Scholar 

  178. Lahey FH, Ficarra BJ. The lateral aberrant thyroid. Surg Gynecol Obstet. 1946;82:705–11. Epub 1946/06/01. PubMed PMID: 20983141.

    CAS  PubMed  Google Scholar 

  179. Rabinov CR, Ward PH, Pusheck T. Evolution and evaluation of lateral cystic neck masses containing thyroid tissue: “lateral aberrant thyroid” revisited. Am J Otolaryngol. 1996;17(1):12–5. Epub 1996/01/01. PubMed PMID: 8801808.

    CAS  PubMed  Google Scholar 

  180. Hassell LA, Gillies EM, Dunn ST. Cytologic and molecular diagnosis of thyroid cancers: is it time for routine reflex testing? Cancer Cytopathol. 2012;120(1):7–17. Epub 2011/09/02. doi: 10.1002/cncy.20186, PubMed PMID: 21882358.

    CAS  PubMed  Google Scholar 

  181. Hogan AR, Zhuge Y, Perez EA, Koniaris LG, Lew JI, Sola JE. Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients. J Surg Res. 2009;156(1):167–72. Epub 2009/07/28. doi: 10.1016/j.jss.2009.03.098, PubMed PMID: 19631341.

    PubMed  Google Scholar 

  182. Perry A, Molberg K, Albores-Saavedra J. Physiologic versus neoplastic C-cell hyperplasia of the thyroid: separation of distinct histologic and biologic entities. Cancer. 1996;77(4):750–6. Epub 1996/02/15. PubMed PMID: 8616768.

    CAS  PubMed  Google Scholar 

  183. Albores-Saavedra JA, Krueger JE. C-cell hyperplasia and medullary thyroid microcarcinoma. Endocr Pathol. 2001;12(4):365–77. Epub 2002/03/27. PubMed PMID: 11914470.

    CAS  PubMed  Google Scholar 

  184. Ganeshan D, Paulson E, Duran C, Cabanillas ME, Busaidy NL, Charnsangavej C. Current update on medullary thyroid carcinoma. Am J Roentgenol. 2013;201(6):W867–76. doi: 10.2214/AJR.12.10370, PubMed PMID: 24261394.

    Google Scholar 

  185. Das DK, Mallik MK, George SS, Sheikh ZA, Pathan SK, Haji BE, et al. Secretory activity in medullary thyroid carcinoma: a cytomorphological and immunocytochemical study. Diagn Cytopathol. 2007;35(6):329–37. Epub 2007/05/15. doi: 10.1002/dc.20637, PubMed PMID: 17497663.

    PubMed  Google Scholar 

  186. Reches M, Porat Y, Gazit E. Amyloid fibril formation by pentapeptide and tetrapeptide fragments of human calcitonin. J Biol Chem. 2002;277(38):35475–80. Epub 2002/07/04. doi: 10.1074/jbc.M206039200, PubMed PMID: 12095997.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgment

The section on Melanotic Neuroectodermal Tumor of Infancy was written by Dr. Bruce R. Pawel and Dr. Rakhee Kisan Sansgiri.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David M. Parham M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Yu, Z., Parham, D.M., Kukreja, M.K. (2015). Pediatric Cancer in the Head and Neck. In: Parham, D., Khoury, J., McCarville, M. (eds) Pediatric Malignancies: Pathology and Imaging. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1729-7_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1729-7_7

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1728-0

  • Online ISBN: 978-1-4939-1729-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics